67.80USD-1.01%Mkt Cap: 4.19B USDP/E: —Last update: 2026-06-01
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food…
Industry Peers
Diagnostics & Research183.26BUSDP/E 27.1
127.46BUSDP/E 35.0
45.09BUSDP/E 42.1
38.48BUSDP/E 27.4
37.00BUSDP/E 47.9
34.66BCHFP/E 38.1
31.51BUSD—
31.45BUSDP/E 23.4
Indicators:|
Key Statistics
Company
Market Cap4.19B USD
Enterprise Value4.10B USD
Revenue (TTM)409.48M USD
Gross Profit191.00M USD
Net Income (TTM)-77.67M USD
Revenue/Share6.735 USD
Last Price67.80 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees979
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS90184D1000
Valuation
P/E (Trailing)—
P/E (Forward)-32.62
PEG—
EV/EBITDA-37.34
EV/Revenue10.01
P/S10.17
P/B9.13
EPS (TTM)-1.32
EPS (Forward)-2.05
52W Range
23.3093% of range71.04
52W High71.04 USD
52W Low23.30 USD
Profitability
Gross Margin50.72%
Oper. Margin-34.92%
EBITDA Margin-26.82%
Profit Margin-20.63%
ROE-16.42%
ROA-12.10%
Growth
Revenue Growth19.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-47.63M USD
CapEx (TTM)28.00M USD
FCF Margin-14.28%
FCF Yield-1.40%
Net Debt-60.83M USD
Net Debt/EBITDA0.55
Balance Sheet
Debt/Equity0.16
Current Ratio2.70
Quick Ratio2.04
Book Value/Sh7.322 USD
Cash/Share2.757 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)64.44 USD
Target Range36.00 USD – 80.00 USD
# Analysts9
Ownership
Shares Out.62.27M
Float55.41M
Insiders1.30%
Institutions123.96%
Short Interest
Short Ratio11.3d
Short % Float34.16%
Short % Out.26.62%
Shares Short16.58M
Short (prev mo.)14.52M
Technical
SMA 5054.74 (+23.9%)
SMA 20039.87 (+70.0%)
Beta2.23
S&P 52W Chg27.70%
Avg Vol (30d)1.41M
Avg Vol (10d)1.77M
Technical Indicators
RSI (14)69.7
MACD2.7349
MACD Signal1.2424
MACD Hist.+1.4926
BB Upper69.13 USD
BB Middle57.77 USD
BB Lower46.42 USD
BB Width39.29%
ATR (14)4.124 USD
Vol Ratio (20d)0.70x